Muralidhar Bali has filed 4 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 30000 shares of SPRUCE BIOSCIENCES, INC. ($SPRB) on July 22, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 22, 2025 | SPRUCE BIOSCIENCES, INC. | $SPRB | Muralidhar Bali | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 42,231,285 | 9999.99% | 0.07% |
| May 22, 2024 | SPRUCE BIOSCIENCES, INC. | $SPRB | Muralidhar Bali | Not found | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| June 6, 2023 | OnKure Therapeutics, Inc. | $OKUR | Muralidhar Bali | Director | A | Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 0 | 9999.99% | 0.00% |
| May 25, 2023 | SPRUCE BIOSCIENCES, INC. | $SPRB | Muralidhar Bali | Director | A | Stock Option (Right to Buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |